Compensatory hemagglutinin mutations alter antigenic properties of influenza viruses

Journal of Virology

Volumn 87, Issue 20, 2013, Pages 11168-11172

  Myers, Jaclyn L ^a   Wetzel, Katherine S ^a,b   Linderman, Susanne L ^a,b   Li, Yang ^a,b   Sullivan, Colleen B ^a   Hensley, Scott E ^a,b  

^a WISTAR INSTITUTE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; INFLUENZA VIRUS HEMAGGLUTININ; SIALIC ACID RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIGENICITY; ARTICLE; CONTROLLED STUDY; INFLUENZA VIRUS; MUTATION; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; REVERSE GENETICS; VIRUS REPLICATION;

ANIMALS; ANTIGENIC VARIATION; ANTIGENS, VIRAL; CHICK EMBRYO; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; MUTANT PROTEINS; MUTATION, MISSENSE; N-ACETYLNEURAMINIC ACID; NEURAMINIDASE; ORTHOMYXOVIRIDAE; PROTEIN BINDING; RECEPTORS, VIRUS; REVERSE GENETICS; SUPPRESSION, GENETIC; VIRAL PROTEINS;

EID: 84886911249     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01414-13     Document Type: Article

References (23)

1. Carrat F, Flahault A. 2007. Influenza vaccine: the challenge of antigenic drift. Vaccine 25:6852-6862.
2. Schultz-Cherry S, Jones JC. 2010. Influenza vaccines: the good, the bad, and the eggs. Adv. Virus Res. 77:63-84.
3. Stohr K, Bucher D, Colgate T, Wood J. 2012. Influenza virus surveillance, vaccine strain selection, and manufacture. Methods Mol. Biol. 865: 147-162.
4. Gerhard W, Yewdell J, Frankel ME, Webster R. 1981. Antigenic structure of influenza virus haemagglutinin defined by hybridoma antibodies. Nature 290:713-717.
5. Caton AJ, Brownlee GG, Yewdell JW, Gerhard W. 1982. The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype). Cell 31:417-427.
6. Das SR, Hensley SE, David A, Schmidt L, Gibbs JS, Puigbo P, Ince WL, Bennink JR, Yewdell JW. 2011. Fitness costs limit influenza A virus hemagglutinin glycosylation as an immune evasion strategy. Proc. Natl. Acad. Sci. U. S. A. 108:E1417-E1422.
7. Hensley SE, Das SR, Gibbs JS, Bailey AL, Schmidt LM, Bennink JR, Yewdell JW. 2011. Influenza A virus hemagglutinin antibody escape promotes neuraminidase antigenic variation and drug resistance. PLoS One 6:e15190. doi:10.1371/journal.pone.0015190.
8. Gen F, Yamada S, Kato K, Akashi H, Kawaoka Y, Horimoto T. 2013. Attenuation of an influenza A virus due to alteration of its hemagglutininneuraminidase functional balance in mice. Arch. Virol. 158:1003-1011.
9. Mitnaul LJ, Matrosovich MN, Castrucci MR, Tuzikov AB, Bovin NV, Kobasa D, Kawaoka Y. 2000. Balanced hemagglutinin and neuraminidase activities are critical for efficient replication of influenza A virus. J. Virol. 74:6015-6020.
10. Myers JL, Hensley SE. 2011. Oseltamivir-resistant influenza viruses get by with a little help from permissive mutations. Expert Rev. Anti Infect. Ther. 9:385-388.
11. Wagner R, Matrosovich M, Klenk HD. 2002. Functional balance between haemagglutinin and neuraminidase in influenza virus infections. Rev. Med. Virol. 12:159-166.
12. Xu R, Zhu X, McBride R, Nycholat CM, Yu W, Paulson JC, Wilson IA. 2012. Functional balance of the hemagglutinin and neuraminidase activities accompanies the emergence of the 2009 H1N1 influenza pandemic. J. Virol. 86:9221-9232.
13. Hensley SE, Das SR, Bailey AL, Schmidt LM, Hickman HD, Jayaraman A, Viswanathan K, Raman R, Sasisekharan R, Bennink JR, Yewdell JW. 2009. Hemagglutinin receptor binding avidity drives influenza A virus antigenic drift. Science 326:734-736.
14. Li Y, Bostick DL, Sullivan CB, Myers JL, Griesemer SB, St George K, Plotkin JB, Hensley SE. 2013. Single hemagglutinin mutations that alter both antigenicity and receptor binding avidity influence influenza virus antigenic clustering. J. Virol. 87:9904-9910.
15. O'Donnell CD, Vogel L, Wright A, Das SR, Wrammert J, Li GM, McCausland M, Zheng NY, Yewdell JW, Ahmed R, Wilson PC, Subbarao K. 2012. Antibody pressure by a human monoclonal antibody targeting the 2009 pandemic H1N1 virus hemagglutinin drives the emergence of a virus with increased virulence in mice. mBio 3:pii: e00120-12. doi:10.1128/mBio.00120-12.
16. Underwood PA, Skehel JJ, Wiley DC. 1987. Receptor-binding characteristics of monoclonal antibody-selected antigenic variants of influenza virus. J. Virol. 61:206-208.
17. Yewdell JW, Caton AJ, Gerhard W. 1986. Selection of influenza A virus adsorptive mutants by growth in the presence of a mixture of monoclonal antihemagglutinin antibodies. J. Virol. 57:623-628.
18. Gerhard W. 2001. The role of the antibody response in influenza virus infection. Curr. Top. Microbiol. Immunol. 260:171-190.
19. Wang ML, Skehel JJ, Wiley DC. 1986. Comparative analyses of the specificities of anti-influenza hemagglutinin antibodies in human sera. J. Virol. 57:124-128.
20. Lakdawala SS, Lamirande EW, Suguitan AL, Jr, Wang W, Santos CP, Vogel L, Matsuoka Y, Lindsley WG, Jin H, Subbarao K. 2011. Eurasianorigin gene segments contribute to the transmissibility, aerosol release, and morphology of the 2009 pandemic H1N1 influenza virus. PLoS Pathog. 7:e1002443. doi:10.1371/journal.ppat.1002443.
21. Kryazhimskiy S, DushoffJ, Bazykin GA, Plotkin JB. 2011. Prevalence of epistasis in the evolution of influenza A surface proteins. PLoS Genet. 7:e1001301. doi:10.1371/journal.pgen.1001301.
22. Nelson MI, Simonsen L, Viboud C, Miller MA, Taylor J, George KS, Griesemer SB, Ghedin E, Sengamalay NA, Spiro DJ, Volkov I, Grenfell BT, Lipman DJ, Taubenberger JK, Holmes EC. 2006. Stochastic processes are key determinants of short-term evolution in influenza a virus. PLoS Pathog. 2:e125. doi:10.1371/journal.ppat.0020125.
23. Ginting TE, Shinya K, Kyan Y, Makino A, Matsumoto N, Kaneda S, Kawaoka Y. 2012. Amino acid changes in hemagglutinin contribute to the replication of oseltamivir-resistant H1N1 influenza viruses. J. Virol. 86: 121-127